Chloramphenicol/Deoxyribonuclease/Fibrinolysin

N/A

Report date: 2025/07/01 15:28:04

Base Information

Drug NameChloramphenicol/Deoxyribonuclease/Fibrinolysin
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of Action50S ribosomal subunit inhibitorsDNA inhibitorsFibrinogen stimulants
Targets50S ribosomal subunitDNAFibrinogen
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1964/04/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesParke Davis Ltd
China Registration ClassN/A

Develop Information

Active CompaniesParke Davis Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A